BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19173293)

  • 1. DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.
    Vella V; Puppin C; Damante G; Vigneri R; Sanfilippo M; Vigneri P; Tell G; Frasca F
    Int J Cancer; 2009 Jun; 124(11):2539-48. PubMed ID: 19173293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function.
    Vilgelm A; Wei JX; Piazuelo MB; Washington MK; Prassolov V; El-Rifai W; Zaika A
    Oncogene; 2008 Apr; 27(15):2170-6. PubMed ID: 17952118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
    Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
    J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs.
    Sabatino MA; Previdi S; Broggini M
    Int J Cancer; 2007 Feb; 120(3):506-13. PubMed ID: 17096333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
    Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
    Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questioning the oncogenic role of DeltaNp73alpha in different cell lines expressing p53 or not.
    Marrazzo E; Marchini S; Previdi S; Broggini M
    Cancer Biol Ther; 2006 Jul; 5(7):794-803. PubMed ID: 16721041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
    Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
    Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization.
    Accardi R; Scalise M; Gheit T; Hussain I; Yue J; Carreira C; Collino A; Indiveri C; Gissmann L; Sylla BS; Tommasino M
    Mol Cell Biol; 2011 Jun; 31(11):2210-26. PubMed ID: 21482671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.
    Evans JR; Bosman JD; Brown-Endres L; Yehiely F; Cryns VL
    Breast Cancer Res Treat; 2010 Jul; 122(1):159-68. PubMed ID: 19777343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DeltaNp73 can modulate the expression of various genes in a p53-independent fashion.
    Kartasheva NN; Lenz-Bauer C; Hartmann O; Schäfer H; Eilers M; Dobbelstein M
    Oncogene; 2003 Nov; 22(51):8246-54. PubMed ID: 14614448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 tumor-suppressor activity is impaired in human thyroid cancer.
    Frasca F; Vella V; Aloisi A; Mandarino A; Mazzon E; Vigneri R; Vigneri P
    Cancer Res; 2003 Sep; 63(18):5829-37. PubMed ID: 14522906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α.
    Accardi R; Fathallah I; Gruffat H; Mariggiò G; Le Calvez-Kelm F; Voegele C; Bartosch B; Hernandez-Vargas H; McKay J; Sylla BS; Manet E; Tommasino M
    PLoS Pathog; 2013 Mar; 9(3):e1003186. PubMed ID: 23516355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.
    Zhang C; Comai L; Johnson DL
    Mol Cell Biol; 2005 Aug; 25(16):6899-911. PubMed ID: 16055704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor.
    Uramoto H; Wetterskog D; Hackzell A; Matsumoto Y; Funa K
    J Cell Sci; 2004 Oct; 117(Pt 22):5323-31. PubMed ID: 15454570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells.
    Taverniti V; Krynska H; Venuti A; Straub ML; Sirand C; Lohmann E; Romero-Medina MC; Moro S; Robitaille A; Negroni L; Martinez-Zapien D; Masson M; Tommasino M; Zanier K
    mSphere; 2023 Apr; 8(2):e0005623. PubMed ID: 36883841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netrin-1 induces apoptosis in human cervical tumor cells via the TAp73alpha tumor suppressor.
    Roperch JP; El Ouadrani K; Hendrix A; Emami S; De Wever O; Melino G; Gespach C
    Cancer Res; 2008 Oct; 68(20):8231-9. PubMed ID: 18922894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells.
    Tell G; Pines A; Arturi F; Cesaratto L; Adamson E; Puppin C; Presta I; Russo D; Filetti S; Damante G
    Endocrinology; 2004 Oct; 145(10):4660-6. PubMed ID: 15231710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.